Health

GC Green Cross: COVID-19 mRNA Vaccine Trial Selected by KDCA

by Archynetys Health Desk

Green Cross within the year corona19 The goal is to obtain IND approval for phase 1 clinical trials for the mRNA vaccine candidate. Last September, an IND application was submitted to the Ministry of Food and Drug Safety and currently…

The Archynetys Health Desk covers public health, medical research, healthcare systems, wellness trends, and science-backed developments that affect readers globally. This desk applies added care to sourcing, evidence, nuance, and plain-language explanation, especially on high-impact health topics.

Related Posts

Google Approves Release of 32M Mosquitoes to Fight...

Cabbage’s Vitamin C, K, Fiber Boost Immune, Digestive...

குழந்தைகளுக்கு சளி, இருமல் வராமல் தடுப்பது எப்படி?

Spektakel am Nachthimmel im Juni: Erdbeermond trifft auf...

WHO calls for community cooperation to contain Ebola...

Premature baby journey supported by Little Miracles

क्या सिरोसिस को लिवर खुद से ठीक कर...

Perinatal Term Shift Enhances Maternal Mental Health Care

EMA and FDA Face Pressure to Re-evaluate Excipient...

WHO chief visits epicentre of the Ebola outbreak...

Leave a Comment